Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	Exclusion Criteria: <br/ >1.Receipt of pooled immunoglobulin in past 30 days <br/ >2.Contraindication to transfusion or history of prior reactions to transfusion blood products <br/ >3.Critically ill patients: <br/ >PaO2/ FiO2 ratio <200 (moderate - severe ARDS) <br/ >Shock <br/ > <br/ >4.Participating in any other clinical trial <br/ >5.Clinical status precluding infusion of blood products <br/ > <br/ >6.Female subjects with positive pregnancy test, breastfeeding, or planning to become pregnant/breastfeed during the study period <br/ >	Exclusion Criteria: <br/ >1.Receipt of pooled immunoglobulin in past 30 days <br/ >2.Contraindication to transfusion or history of prior reactions to transfusion blood products <br/ >3.Critically ill patients: <br/ >PaO2/ FiO2 ratio <200 (moderate - severe ARDS) <br/ >Shock <br/ > <br/ >4.Participating in any other clinical trial <br/ >5.Clinical status precluding infusion of blood products <br/ > <br/ >6.Female subjects with positive pregnancy test, breastfeeding, or planning to become pregnant/breastfeed during the study period <br/ >
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Oct. 26, 2020, 8:29 a.m.	oms	Exclusion Criteria: <br/ >1.Receipt of pooled immunoglobulin in past 30 days <br/ >2.Contraindication to transfusion or history of prior reactions to transfusion blood products <br/ >3.Critically ill patients: <br/ >PaO2/ FiO2 ratio <200 (moderate - severe ARDS) <br/ >Shock <br/ > <br/ >4.Participating in any other clinical trial <br/ >5.Clinical status precluding infusion of blood products <br/ > <br/ >6.Female subjects with positive pregnancy test, breastfeeding, or planning to become pregnant/breastfeed during the study period <br/ >	Exclusion Criteria: <br/ >1.Receipt of pooled immunoglobulin in past 30 days <br/ >2.Contraindication to transfusion or history of prior reactions to transfusion blood products <br/ >3.Critically ill patients: <br/ >PaO2/ FiO2 ratio <200 (moderate - severe ARDS) <br/ >Shock <br/ > <br/ >4.Participating in any other clinical trial <br/ >5.Clinical status precluding infusion of blood products <br/ > <br/ >6.Female subjects with positive pregnancy test, breastfeeding, or planning to become pregnant/breastfeed during the study period <br/ >